論文・技術情報追加のお知らせ

①Urinary tract infection following the use of BTK inhibitors: a real-world analysis of post-marketing surveillance data.

BTK阻害剤と尿路感染症との関連性評価研究

対象DB：FAERS

②Ocular adverse Events of cenegermin Used in neurotrophic Keratopathy: An Analysis of the FDA adverse event reporting system Database.

神経栄養性角膜症患者における、セネゲルミンによる眼関連の有害事象評価研究

対象DB：FAERS

③Evaluating Ubrogepant-related adverse events using the FDA adverse event reporting system.

ウブロゲパントによる有害事象評価研究

対象DB：FAERS

④Cardiovascular toxicities following the use of tyrosine kinase inhibitors in Hepatocellular Cancer Patients: A Retrospective, Pharmacovigilance Study.

肝細胞癌患者における、チロシンキナーゼ阻害剤による心疾患系有害事象調査研究

対象DB：FAERS

⑤Analysis of the association between Janus kinase inhibitors and malignant skin tumors using the Food and Drug Administration Adverse Event Reporting System.

ヤヌスキナーゼ阻害薬と悪性皮膚腫瘍との関連性評価研究

対象DB：FAERS

⑥Causes of Drug-Induced Severe Cutaneous Adverse Reaction Epidermal Necrolysis (EN): An Analysis Using FDA Adverse Event Reporting System (FAERS) Database.

Stevens-Johnson症候群および中毒性表皮壊死症に関連する薬剤探索研究

対象DB：FAERS

⑦META-INSTI: metabolic adverse events following integrase strand transfer inhibitor administration in spontaneous adverse event reports.

インテグラーゼ阻害薬と代謝性有害事象との関係性評価研究

対象DB：FAERS

⑧Pharmacovigilance Study on Eosinophilic Pneumonia Induced by Anti-MRSA Agents: Analysis Based on the FDA Adverse Event Reporting System.

抗MRSA薬と好酸球性肺炎との関係性評価研究

対象DB：FAERS